May 15, 2025 · Published in The New England Journal of Medicine on May 11, 2025, this phase 3b, open-label, randomized trial compares the efficacy and safety of tirzepatide (10 or 15 mg …

May 15, 2025 · Published in The New England Journal of Medicine on February 10, 2021, this study investigates the efficacy and safety of once-weekly subcutaneous semaglutide (2.4 mg) …

Published in The New England Journal of Medicine on February 10, 2021, this study investigates the efficacy and safety of once-weekly subcutaneous semaglutide (2.4 mg) for weight loss in …

May 15, 2025 · This study establishes oral semaglutide as a safe and effective option for managing type 2 diabetes in patients with high cardiovascular risk, offering glycemic control, …

Research Peptides disclaims any liability for research outcomes, data loss, or other consequences arising from the use of our products. As stated in our Terms and Conditions, all …

Jun 4, 2025 · Risk of Loss: Risk of loss and title for products pass to you upon delivery to the carrier. Research Peptides is not responsible for loss, damage, or theft during transit.

About Research Peptides Research Peptides™ is a premier supplier of research peptides. We have established partnerships with WHO/GMP and ISO 9001:2015 certified manufacturers to …

IGF1-LR3 (Insulin-like Growth Factor-1 Long R3) is a high-purity synthetic peptide, an 83-amino acid analogue of IGF-1 with an extended half-life due to arginine substitution at position 3 and …

Heading H1 – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam fringilla commodo pretium condimentum Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam fringilla …

May 15, 2025 · About: Research Corner is provided as a dataset to share articles that researchers may or may not be aware of. The synopsis is provided and link to the orginal study or article is …